23andMe may disclose your personal and genetic data to law enforcement, government agencies, or courts in response to valid legal requests such as subpoenas, warrants, or court orders.
This analysis describes what 23andMe's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
This provision defines the operational boundary between 23andMe's general data protection practices and mandatory disclosure obligations imposed by legal authority. It establishes that genetic and personal data held by 23andMe remains subject to compulsory legal disclosure mechanisms, regardless of the company's privacy commitments.
Removal of explicit law enforcement disclosure provision eliminates transparency about government access to genetic data, a critical privacy safeguard previously highlighted.
View full change record →Users have no guaranteed right to be notified before their genetic data is disclosed to law enforcement, and the policy does not commit to challenging overbroad legal requests. This is particularly significant given that genetic data can implicate biological relatives who are not 23andMe customers.
How other platforms handle this
we may use, retain or share information with law enforcement or others in circumstances where a person's vital interests require protection, such as in the case of emergencies.
disclosure is required by a third-party to complete a transaction initiated by the user
We will disclose information to third parties about your account or the transfers you make: (i) where it is necessary for completing transfers, or (ii) in order to verify the existence and condition of your account...
This provision requires assessment against GDPR Article 23 restrictions on law enforcement access, CCPA exemptions for legal compliance, and HIPAA law enforcement disclosure rules applicable to telehealth data; the absence of a transparency report commitment …
Enforcement risk, jurisdiction flags, contract triggers, and due diligence action items.
ConductAtlas detected a major restructuring of Meta’s privacy policy that removed detailed consumer rights disclosures and relocated them to separate documents.
Your genetic data may be transferred to a new owner as a business asset. Here is what the Terms of Service actually say and what you can do right now.
Get the research letter
Companies change their terms quietly. We read every version and catch what actually changed. One email a week on the changes that matter and what they mean.
This provision defines the operational boundary between 23andMe's general data protection practices and mandatory disclosure obligations imposed by legal authority. It establishes that genetic and personal data held by 23andMe remains subject to compulsory legal disclosure mechanisms, regardless of the company's privacy commitments.
Users have no guaranteed right to be notified before their genetic data is disclosed to law enforcement, and the policy does not commit to challenging overbroad legal requests. This is particularly significant given that genetic data can implicate biological relatives who are not 23andMe customers.
ConductAtlas has identified this type of provision across 288 platforms. See the full comparison.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by 23andMe.